InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: maumar post# 4605

Sunday, 06/05/2016 5:29:39 PM

Sunday, June 05, 2016 5:29:39 PM

Post# of 8490
That data was/is very confusing to me. Spent well over 2 hours between pr, poster and clinical trial design.

Just looking at last cohort, cohort 7, which was the largest with 8 patients.

Time on treatment ranged from less than one month to 13 months. The average was 4.4 months on treatment. One patient that did not complete the first cycle lived 20 months. The patient with 13 months on treatment lived 22 months. Another patient with two months on treatment lived 15 months. Four received treatment longer than 2 months and two longer than 5 months.

I have no idea how this data interprets but I do understand why PFS was not reported.


Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News